Oncopathology or cancer pathology is a specialised branch of pathology focused on diagnosing and characterising tumours ...

It tends to be more aggressive and challenging to treat. HER2 Testing HER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative.

HER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for HER2 testing if the cancer is invasive, metastatic, and/or recurrent.

John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of ...

This precision medicine approach, driven by granular, real-world evidence, is critical for reshaping clinical guidelines and ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance ...

Cash runway extended through 2026, beyond September 30, 2026 sunset date for rare pediatric priority review voucher (PRV) program Additional funding allows Company to advance strategic alternatives ...

John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of Successor - - Dr. Houston to Remain Chairperson of Arvinas Board of Directors - ...

The study showed a >95% technical success rate when used with brush biopsy samples, a less invasive alternative to forceps biopsy. With a U.S. clinical launch expected in the next 2–3 quarters, ...

Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.